209 related articles for article (PubMed ID: 10835711)
21. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
[TBL] [Abstract][Full Text] [Related]
22. Oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and risk of bleeding. A Multicenter Inception Cohort Study.
Pengo V; Legnani C; Noventa F; Palareti G;
Thromb Haemost; 2001 Mar; 85(3):418-22. PubMed ID: 11307807
[TBL] [Abstract][Full Text] [Related]
23. Ximelagatran: a new oral anticoagulant.
Hrebickova L; Nawarskas JJ; Anderson JR
Heart Dis; 2003; 5(6):397-408. PubMed ID: 14633322
[TBL] [Abstract][Full Text] [Related]
24. Assessment of patient capability to self-adjust oral anticoagulant dose: a multicenter study on home use of portable prothrombin time monitor (COAGUCHECK).
Cosmi B; Palareti G; Carpanedo M; Pengo V; Biasiolo A; Rampazzo P; Morstabilini G; Testa S
Haematologica; 2000 Aug; 85(8):826-31. PubMed ID: 10942929
[TBL] [Abstract][Full Text] [Related]
25. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
[TBL] [Abstract][Full Text] [Related]
26. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
[TBL] [Abstract][Full Text] [Related]
27. Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range.
Connolly SJ; Pogue J; Eikelboom J; Flaker G; Commerford P; Franzosi MG; Healey JS; Yusuf S;
Circulation; 2008 Nov; 118(20):2029-37. PubMed ID: 18955670
[TBL] [Abstract][Full Text] [Related]
28. [Dental extractions in patients taking anticoagulants: is alteration of the anticoagulant regime necessary?].
Madrid C
Rev Med Suisse; 2005 May; 1(21):1418, 1421-2, 1424. PubMed ID: 15997980
[TBL] [Abstract][Full Text] [Related]
29. INR variability in atrial fibrillation: a risk model for cerebrovascular events.
Amouyel P; Mismetti P; Langkilde LK; Jasso-Mosqueda G; Nelander K; Lamarque H
Eur J Intern Med; 2009 Jan; 20(1):63-9. PubMed ID: 19237095
[TBL] [Abstract][Full Text] [Related]
30. [The interaction between anticoagulant therapy with vitamin K-antagonists and treatment with antibiotics: a practical recommendation].
Zelis M; Zweegman S; van der Meer FJ; Kramer MH; Smulders YM
Ned Tijdschr Geneeskd; 2008 May; 152(18):1042-6. PubMed ID: 18547025
[TBL] [Abstract][Full Text] [Related]
31. Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment: impact on the international normalized ratio system.
Testa S; Morstabilini G; Fattorini A; Galli L; Denti N; D'Angelo A
Haematologica; 2002 Dec; 87(12):1265-73. PubMed ID: 12495900
[TBL] [Abstract][Full Text] [Related]
32. Thromboembolic and/or bleeding complications in patients under oral anticoagulation followed at a tertiary hospital.
Pelicano N; Branco LM; Pinto A; Sá A; Timóteo AT; Feliciano J; Fiarresga A; Agapito AF; Palma MC; Quininha J
Rev Port Cardiol; 2005; 24(7-8):957-68. PubMed ID: 16240682
[TBL] [Abstract][Full Text] [Related]
33. [Factors influencing activity of oral anticoagulants. Interactions with drugs and food].
Sawicka-Powierza J; Rogowska-Szadkowska D; Ołtarzewska AM; Chlabicz S
Pol Merkur Lekarski; 2008 May; 24(143):458-62. PubMed ID: 18634396
[TBL] [Abstract][Full Text] [Related]
34. Oral anticoagulation therapy in children.
Bonduel MM
Thromb Res; 2006; 118(1):85-94. PubMed ID: 16709477
[TBL] [Abstract][Full Text] [Related]
35. [A retrospective survey on practice of oral anticoagulant therapy in patients with cardiovascular diseases].
Katona A; Márk L
Orv Hetil; 2004 Aug; 145(32):1643-7. PubMed ID: 15384862
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for bleeding during anticoagulation of atrial fibrillation in older and younger patients in clinical practice.
Abdelhafiz AH; Wheeldon NM
Am J Geriatr Pharmacother; 2008 Mar; 6(1):1-11. PubMed ID: 18396243
[TBL] [Abstract][Full Text] [Related]
37. Role of thrombophilia in deciding on the duration of anticoagulation.
Bauer KA
Semin Thromb Hemost; 2004 Dec; 30(6):633-7. PubMed ID: 15630669
[TBL] [Abstract][Full Text] [Related]
38. The INR: a perspective.
Smith RE
Semin Thromb Hemost; 1997; 23(6):547-9. PubMed ID: 9469628
[TBL] [Abstract][Full Text] [Related]
39. Novel anticoagulants and the future of anticoagulation.
Garcia D
Thromb Res; 2009; 123 Suppl 4():S50-5. PubMed ID: 19303505
[TBL] [Abstract][Full Text] [Related]
40. Risks of oral anticoagulant therapy with increasing age.
Torn M; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
Arch Intern Med; 2005 Jul; 165(13):1527-32. PubMed ID: 16009869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
